CellaVision AB(GB:0MR5)
kr 202.50-1.00 (-0.49%)
GB:0MR5
CellaVision AB financials statements
kr 202.50
At close:-1.00 (-0.49%)
CellaVision AB (0MR5) Financial Statements
0 Followers
CellaVision AB Financial Overview
CellaVision AB's market cap is currently kr4.84B. The company's EPS TTM is kr5.78; its P/E ratio is 35.03; and it has a dividend yield of 1.33%. CellaVision AB is estimated to report earnings on February 4, 2027, and the estimated EPS forecast is kr2.03. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 758.97M | kr 723.22M | kr 677.29M | kr 639.34M | kr 565.55M |
| Gross Profit | kr 519.88M | kr 487.07M | kr 463.04M | kr 438.32M | kr 392.30M |
| Operating Income | kr 202.07M | kr 177.68M | kr 167.05M | kr 158.27M | kr 162.73M |
| EBITDA | kr 237.28M | kr 226.02M | kr 207.25M | kr 190.87M | kr 193.60M |
| Net Income | kr 153.08M | kr 140.72M | kr 130.31M | kr 118.33M | kr 125.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 188.22M | kr 149.43M | kr 121.64M | kr 108.05M | kr 130.29M |
| Total Assets | kr 1.09B | kr 1.01B | kr 928.71M | kr 891.75M | kr 825.21M |
| Total Debt | kr 25.65M | kr 26.85M | kr 64.70M | kr 102.50M | kr 136.65M |
| Net Debt | kr -162.56M | kr -122.58M | kr -56.94M | kr -5.56M | kr 6.37M |
| Total Liabilities | kr 207.31M | kr 196.16M | kr 212.32M | kr 250.12M | kr 281.93M |
| Stockholders' Equity | kr 887.58M | kr 815.73M | kr 716.39M | kr 641.63M | kr 543.28M |
| Cash Flow | |||||
| Free Cash Flow | kr 181.72M | kr 186.44M | kr 109.96M | kr 67.85M | kr 75.41M |
| Operating Cash Flow | kr 200.53M | kr 198.44M | kr 196.44M | kr 137.28M | kr 159.72M |
| Investing Cash Flow | kr -86.16M | kr -76.01M | kr -85.53M | kr -70.01M | kr -84.34M |
| Financing Cash Flow | kr -74.59M | kr -95.09M | kr -97.04M | kr -90.41M | kr -48.48M |
Currency in SEK
